{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:37:29Z","timestamp":1760852249515},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2007,3,9]],"date-time":"2007-03-09T00:00:00Z","timestamp":1173398400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.0030048","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T12:50:06Z","timestamp":1173185406000},"page":"e48","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["A Look Inside HIV Resistance through Retroviral Protease Interaction Maps"],"prefix":"10.1371","volume":"3","author":[{"given":"Aleksejs","family":"Kontijevskis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peteris","family":"Prusis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Petrovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sviatlana","family":"Yahorava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felikss","family":"Mutulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilze","family":"Mutule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarl E. S","family":"Wikberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2007,3,9]]},"reference":[{"key":"pcbi-0030048-b001","unstructured":"RosenbergNJolicoeurP 1997 Retroviral pathogenesis. In: CoffinJMHughesSHVarmusH Retroviruses Cold Spring Harbor (New York) Cold Spring Harbor Laboratory Press 475 586"},{"key":"pcbi-0030048-b002","doi-asserted-by":"crossref","unstructured":"Joint United Nations Programme on HIV\/AIDS 2006 2006 Report on the Global AIDS Epidemic: Executive Summary Geneva (Switzerland) UNAIDS 13","DOI":"10.18356\/488a895d-en"},{"key":"pcbi-0030048-b003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nbt0102-15","article-title":"Designing drugs against heterogeneous targets.","volume":"20","year":"2002","journal-title":"Nature Biotechnol"},{"key":"pcbi-0030048-b004","first-page":"4710","article-title":"Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease.","volume":"74","year":"2002","journal-title":"J Virol"},{"key":"pcbi-0030048-b005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1568005024605837","article-title":"Defining HIV-1 protease substrate selectivity.","volume":"2","year":"2002","journal-title":"Curr Drug Targets Infect Disord"},{"key":"pcbi-0030048-b006","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2174\/1568026043388330","article-title":"Peptidomimetic inhibitors of HIV protease.","volume":"4","year":"2004","journal-title":"Curr Top Med Chem"},{"key":"pcbi-0030048-b007","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrd703","article-title":"Strategies in the design of antiviral drugs.","volume":"1","year":"2002","journal-title":"Nature Rev Drug Discov"},{"key":"pcbi-0030048-b008","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/713609213","article-title":"Aspartic peptidase inhibitors: Implications in drug development.","volume":"38","year":"2003","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"pcbi-0030048-b009","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pbiomolbio.2004.07.005","article-title":"Adaptive inhibitors of the HIV-1 protease.","volume":"88","year":"2005","journal-title":"Prog Byophis Mol Biol"},{"key":"pcbi-0030048-b010","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1128\/JVI.75.19.9458-9469.2001","article-title":"Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases.","volume":"75","year":"2001","journal-title":"J Virol"},{"key":"pcbi-0030048-b011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4838(99)00240-X","article-title":"Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase.","volume":"1478","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"pcbi-0030048-b012","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1128\/JVI.77.12.6589-6600.2003","article-title":"Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases.","volume":"77","year":"2003","journal-title":"J Virol"},{"key":"pcbi-0030048-b013","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0167-4838(99)00267-8","article-title":"Structural and biochemical studies of retroviral proteases.","volume":"1477","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"pcbi-0030048-b014","first-page":"3006.1","article-title":"Retroviral proteases.","volume":"3","year":"2002","journal-title":"Genome Biol"},{"key":"pcbi-0030048-b015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-5793(90)81171-J","article-title":"Comparison of inhibitor binding in HIV-1 protease and in non-viral aspartic proteases: The role of the flap.","volume":"269","year":"1990","journal-title":"FEBS Lett"},{"key":"pcbi-0030048-b016","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/jm9700575","article-title":"New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids.","volume":"41","year":"1998","journal-title":"J Med Chem"},{"key":"pcbi-0030048-b017","doi-asserted-by":"crossref","first-page":"32180","DOI":"10.1074\/jbc.271.50.32180","article-title":"Rate-determining steps in HIV-1 protease catalysis.","volume":"271","year":"1996","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b018","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2105-7-167","article-title":"Prediction of indirect interactions in proteins.","volume":"7","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"pcbi-0030048-b019","doi-asserted-by":"crossref","unstructured":"WikbergJESLapinshMPrusisP 2004 Proteochemometrics: A tool for modelling the molecular interaction space. In: KubinyiHMullerG Chemogenomics in drug discovery\u2014A medicinal chemistry perspective Weinheim (Germany) Wiley-VCH 289 309","DOI":"10.1002\/3527603948.ch10"},{"key":"pcbi-0030048-b020","first-page":"14539","article-title":"Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid.","volume":"266","year":"1991","journal-title":"J Virol"},{"key":"pcbi-0030048-b021","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1128\/JVI.76.3.1359-1368.2002","article-title":"Altered substrate specificity of drug-resistant human immunodeficiency virus type 1 protease.","volume":"76","year":"2002","journal-title":"J Virol"},{"key":"pcbi-0030048-b022","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1074\/jbc.271.9.4709","article-title":"Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites.","volume":"271","year":"1996","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b023","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/337615a0","article-title":"Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1.","volume":"337","year":"1989","journal-title":"Nature"},{"key":"pcbi-0030048-b024","first-page":"51","article-title":"Update of the drug resistance mutations in HIV-1: 2005.","volume":"13","year":"2005","journal-title":"Top HIV Med"},{"key":"pcbi-0030048-b025","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/JVI.68.3.2016-2020.1994","article-title":"Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor.","volume":"68","year":"1994","journal-title":"J Virol"},{"key":"pcbi-0030048-b026","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/340397a0","article-title":"Complete mutagenesis of the HIV-1 protease.","volume":"340","year":"1989","journal-title":"Nature"},{"key":"pcbi-0030048-b027","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1046\/j.1432-1033.2002.03105.x","article-title":"Effect of sequence polymorphism and drug resistance on two HIV-1 Gag processing sites.","volume":"269","year":"2002","journal-title":"Eur J Biochem"},{"key":"pcbi-0030048-b028","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/viro.1996.0266","article-title":"Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag\/pol polyproteins: Amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.","volume":"219","year":"1996","journal-title":"Virology"},{"key":"pcbi-0030048-b029","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1128\/JVI.77.8.4836-4847.2003","article-title":"Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments.","volume":"77","year":"2003","journal-title":"J Virol"},{"key":"pcbi-0030048-b030","doi-asserted-by":"crossref","first-page":"9502","DOI":"10.1128\/JVI.75.19.9502-9508.2001","article-title":"Viral evolution in response to the broad-based retroviral protease inhibitor TL-3.","volume":"75","year":"2001","journal-title":"J Virol"},{"key":"pcbi-0030048-b031","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/nar\/29.1.296","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database: An expanded data model integrating natural language text and sequence analysis programs.","volume":"29","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"pcbi-0030048-b032","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1021\/bi980612k","article-title":"Drug-resistant HIV-1 proteases identify enzyme residues important for substrate selection and catalytic rate.","volume":"37","year":"1998","journal-title":"Biochemistry"},{"key":"pcbi-0030048-b033","doi-asserted-by":"crossref","first-page":"11711","DOI":"10.1016\/S0021-9258(19)50258-7","article-title":"Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases.","volume":"268","year":"1993","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b034","doi-asserted-by":"crossref","first-page":"9491","DOI":"10.1016\/S0021-9258(19)50117-X","article-title":"Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates.","volume":"267","year":"1992","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b035","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1021\/bi972183g","article-title":"Structural basis for specificity of retroviral proteases.","volume":"37","year":"1998","journal-title":"Biochemistry"},{"key":"pcbi-0030048-b036","doi-asserted-by":"crossref","first-page":"9481","DOI":"10.1016\/S0021-9258(19)50116-8","article-title":"Mutations that alter the activity of the Rous sarcoma virus protease.","volume":"267","year":"1992","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b037","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1074\/jbc.271.9.4709","article-title":"Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites.","volume":"271","year":"1996","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b038","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0014-5793(91)80186-7","article-title":"Studies on the role of the S4 substrate binding site of HIV proteinases.","volume":"279","year":"1991","journal-title":"FEBS Lett"},{"key":"pcbi-0030048-b039","doi-asserted-by":"crossref","first-page":"23735","DOI":"10.1016\/S0021-9258(18)35899-X","article-title":"Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.","volume":"267","year":"1992","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b040","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1074\/jbc.271.12.6781","article-title":"Comparative studies on the substrate specificity of avian myeloblastosis virus proteinase and lentiviral proteinases.","volume":"271","year":"1996","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b041","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1432-1327.1999.00756.x","article-title":"Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates.","volume":"265","year":"1999","journal-title":"Eur J Biochem"},{"key":"pcbi-0030048-b042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4838(99)00240-X","article-title":"Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase.","volume":"1478","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"pcbi-0030048-b043","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1046\/j.1432-1327.1999.00687.x","article-title":"Effect of substrate residues on the P2\u2032 preference of retroviral proteinases.","volume":"264","year":"1999","journal-title":"Eur J Biochem"},{"key":"pcbi-0030048-b044","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1021\/bi00064a018","article-title":"Studies on the substrate specificity of the proteinase of equine infectious anemia virus using oligopeptide substrates.","volume":"32","year":"1993","journal-title":"Biochemistry"},{"key":"pcbi-0030048-b045","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1128\/JVI.74.10.4710-4720.2000","article-title":"Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease.","volume":"74","year":"2000","journal-title":"J Virol"},{"key":"pcbi-0030048-b046","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1074\/jbc.274.10.6660","article-title":"Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase.","volume":"274","year":"1999","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b047","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1021\/bi00135a008","article-title":"Kinetic and modeling studies of S3-S3\u2032 subsites of HIV proteinases.","volume":"31","year":"1992","journal-title":"Biochemistry"},{"key":"pcbi-0030048-b048","doi-asserted-by":"crossref","first-page":"16807","DOI":"10.1074\/jbc.272.27.16807","article-title":"Studies on the symmetry and sequence context dependence of the HIV-1 proteinase specificity.","volume":"272","year":"1997","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b049","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-5793(91)80362-7","article-title":"Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins.","volume":"281","year":"1991","journal-title":"FEBS Lett"},{"key":"pcbi-0030048-b050","doi-asserted-by":"crossref","first-page":"27148","DOI":"10.1074\/jbc.M401868200","article-title":"Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell leukemia virus type 1 protease.","volume":"279","year":"2004","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b051","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1432-1327.1999.00514.x","article-title":"Structural and kinetic analysis of drug resistant mutants of HIV-1 protease.","volume":"263","year":"1999","journal-title":"Eur J Biochem"},{"key":"pcbi-0030048-b052","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1046\/j.1432-1033.2002.03105.x","article-title":"Effect of sequence polymorphism and drug resistance on two HIV-1 Gag processing sites.","volume":"269","year":"2002","journal-title":"Eur J Biochem"},{"key":"pcbi-0030048-b053","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/prot.10140","article-title":"Combining mutations in HIV-1 protease to understand mechanisms of resistance.","volume":"48","year":"2002","journal-title":"Proteins Struct Funct Genet"},{"key":"pcbi-0030048-b054","doi-asserted-by":"crossref","first-page":"16795","DOI":"10.1016\/S0021-9258(19)89462-0","article-title":"Kinetic and modeling studies of subsites S4-S3\u2032 of Moloney murine leukemia virus protease.","volume":"269","year":"1994","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b055","doi-asserted-by":"crossref","first-page":"29162","DOI":"10.1074\/jbc.270.49.29162","article-title":"Mutational analysis of the substrate binding pocket of murine leukemia virus protease and comparison with human immunodeficiency virus proteases.","volume":"270","year":"1995","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b056","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1128\/JVI.71.3.2083-2091.1997","article-title":"Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.","volume":"71","year":"1997","journal-title":"J Virol"},{"key":"pcbi-0030048-b057","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1074\/jbc.271.18.10538","article-title":"Programming the Rous sarcoma virus protease to cleave new substrate sequences.","volume":"271","year":"1996","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b058","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1046\/j.1432-1327.2000.01714.x","article-title":"Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases.","volume":"267","year":"2000","journal-title":"Eur J Biochem"},{"key":"pcbi-0030048-b059","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0965-9978(98)00046-5","article-title":"Artificial neural network model for predicting HIV protease cleavage sites in protein.","volume":"29","year":"1998","journal-title":"Adv Eng Softw"},{"key":"pcbi-0030048-b060","doi-asserted-by":"crossref","first-page":"14548","DOI":"10.1016\/S0021-9258(18)98721-1","article-title":"Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus.","volume":"266","year":"1991","journal-title":"J Biol Chem"},{"key":"pcbi-0030048-b061","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1073\/pnas.87.16.6336","article-title":"Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein.","volume":"87","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pcbi-0030048-b062","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/pro.5560021216","article-title":"Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease.","volume":"2","year":"1993","journal-title":"Protein Sci"},{"key":"pcbi-0030048-b063","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1097-0134(199601)24:1<51::AID-PROT4>3.0.CO;2-R","article-title":"Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method.","volume":"24","year":"1996","journal-title":"Proteins Struct Funct Genet"},{"key":"pcbi-0030048-b064","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/BF01024929","article-title":"Studies on the specificity of HIV protease: An application of markov chain theory.","volume":"12","year":"1993","journal-title":"J Protein Chem"},{"key":"pcbi-0030048-b065","unstructured":"Umetrics AB 2001 Simca-P 9 User Guide and Tutorial >Ume\u00e5 (Sweden) Umetrics AB"},{"key":"pcbi-0030048-b066","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-7439(98)00065-3","article-title":"Experimental design and optimization.","volume":"42","year":"1998","journal-title":"Chemometr Intell Lab Syst"},{"key":"pcbi-0030048-b067","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/00401706.1978.10489693","article-title":"Cross-validatory estimation of the number of components in factor and principal components models.","volume":"20","year":"1978","journal-title":"Technometrics"},{"key":"pcbi-0030048-b068","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/cem.1180070407","article-title":"A test of significance for partial least squares regression.","volume":"7","year":"1993","journal-title":"J Chemomet"},{"key":"pcbi-0030048-b069","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/01621459.1987.10478410","article-title":"Better bootstrap confidence intervals and approximations.","volume":"82","year":"1987","journal-title":"J Am Stat Assoc"},{"key":"pcbi-0030048-b070","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/protein\/15.4.305","article-title":"Proteo-chemometrics analysis of MSH peptide binding to melanocortin receptors.","volume":"15","year":"2002","journal-title":"Protein Eng"},{"key":"pcbi-0030048-b071","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: Visual molecular dynamics.","volume":"14","year":"1996","journal-title":"J Mol Graphics"},{"key":"pcbi-0030048-b072","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4615-5373-1_13","article-title":"Investigation of an allosteric site of HIV-1 proteinase involved in inhibition by Cu2+.","volume":"436","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"pcbi-0030048-b073","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-5193(89)80059-1","article-title":"Optimal design for model discrimination using the F-test with nonlinear biochemical models. Criteria for choosing the number and spacing of experimental points.","volume":"139","year":"1989","journal-title":"J Theor Biol"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.0030048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T21:43:13Z","timestamp":1683754993000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.0030048"}},"subtitle":[],"editor":[{"given":"John H","family":"Elder","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,3,9]]},"references-count":73,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2007,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.0030048","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,9]]}}}